Hepatitis B is a liver infection caused by the hepatitis B virus (HBV). Hepatitis B is transmitted when blood, semen, or another body fluid from a person infected with the virus enters the body of someone who is not infected. This can happen through sexual contact; sharing needles, syringes, other injection equipment; or from mother to baby at birth.
For many, especially children, hepatitis B infection is asympomatic. For some people, including most infected in infancy, hepatitis B can become a long-term, chronic infection. Chronic hepatitis B can lead to serious health issues, like cirrhosis or liver cancer.
The first dose of hepatitis B vaccine is given at birth, with the three-dose series completed between 6 and 18 months of age. Older children and adolescents who did not previously receive the hepatitis B vaccine should be immunized.
Source: Centers for Disease Control and Prevention
You will find below all of the resources you will need about the hepatitis B vaccine. More will be added as they are published or released.
| Information Paper |
Date |
| Hepatitis B Infection and Hepatitis B Vaccines |
Dec. 6, 2017 |
|
Counting Doses in Combined Regimens of Monovalent and Bivalent Hepatitis A and Hepatitis B vaccines
|
Aug. 30, 2019
|
| Standing Orders |
Date |
Hepatitis B Vaccine (Pediatric)
|
April 6, 2023 |
Hepatitis B Vaccine (Adult)
|
May 17, 2023 |
| Vaccine Information Statements (VIS) |
Date |
Hepatitis B Vaccine: What You Need to Know
|
May 12, 2023 |
Your Child's First Vaccines
|
Oct. 15, 2021
|
| Manufacturer Package Inserts |
Date |
Engerix-B
|
Dec. 19, 2018 |
Heplisav-B
|
May 6, 2020 |
Pediarix
|
April 26, 2023 |
PREHIVBRIO
|
Nov. 30, 2021 |
Recombivax HB
|
Dec. 21, 2018 |
Twinrix
|
Dec. 18, 2018
|
Vaxelis
|
April 12, 2023
|
| Advisory Committee on Immunization Practices (ACIP) Recommendations |
Date |
Hepatitis B Vaccine
|
April 20, 2018 |
You also may be interested in...
Fact Sheet
8/30/2019
This information paper describes the required number of doses, using various combinations of monovalent (single antigen) hepatitis A and hepatitis B vaccines and the bivalent (combination hepatitis A and hepatitis B) vaccine, to ensure adequate immunity against both diseases.
Report
3/1/2019
In 1990, chronic hepatitis B virus infection in the World Health Organization Western Pacific Region (WPR) was highly endemic. During 2005-2017, increases in coverage for both the hepatitis B vaccine birth dose and third dose led to a decline in prevalence of chronic hepatitis infection in children to <1% in 25 countries.
Publication
11/1/2018
Hepatitis B degrades the health and military operational capabilities of those affected and demands significant health care resources for its clinical management.
Report
5/18/2018
The CDC funded three programs to develop hepatitis B testing and linkage-to-care programs serving non–U.S.-born persons during 2014–2017; 78% of persons with chronic HBV infection were linked to care using community-based services.
Report
4/20/2018
In November 2017, a single-antigen Hepatitis B vaccine with a novel immunostimulatory sequence adjuvant was approved by the Food and Drug The Advisory Committee on Immunization Practices (ACIP) has recommended this vaccine for use in persons aged ≥18 years.
Report
3/16/2018
In March 2017, a hemodialysis clinic reported a patient who had tested negative for hepatitis B virus (HBV) surface antigen (HBsAg) after vaccination in 2010 and who later tested positive for HBsAg. A public health investigation subsequently determined that the false-negative results were caused by a surface antigen mutation.
Report
2/23/2018
An increase in acute hepatitis B virus infections in Florida led to targeted outreach for testing and vaccination programs for persons at high risk, and resulted in the administration of more than 300 doses of hepatitis B vaccine.
Report
1/12/2018
This report updates and summarizes previously published recommendations from the Advisory Committee on Immunization Practices (ACIP) and CDC regarding the prevention of Hepatitis B virus infection in the United States.
Fact Sheet
12/6/2017
This information paper describes hepatitis B virus and the vaccines to prevent it.
Fact Sheet
8/30/2017
This information paper provides immunization recommendations and resources for Department of Defense (DOD) personnel supporting disaster response operations, both in CONUS and OCONUS.
Fact Sheet
10/19/2016
This fact sheet provides the dosing schedule for MMR, Varicella, Hepatitis A and Hepatitis B vaccines.
Page 1 of 1
, showing items 1 - 12
You are leaving Health.mil
The appearance of hyperlinks does not constitute endorsement by the Department of Defense of non-U.S. Government sites or the information, products, or services contained therein. Although the Defense Health Agency may or may not use these sites as additional distribution channels for Department of Defense information, it does not exercise editorial control over all of the information that you may find at these locations. Such links are provided consistent with the stated purpose of this website.
You are leaving Health.mil
View the external links disclaimer.
Last Updated: May 23, 2023